Connect with us

Business

AstraZeneca COVID-19 vaccine trial volunteer ‘had neurological symptoms’ – Sydney Morning Herald

A woman in the trial in the UK had symptoms consistent with a rare but serious spinal inflammatory disorder, according to a report.

Published

on

AstraZeneca said a woman in the United Kingdom had symptoms consistent with a rare but serious spinal inflammatory disorder, which led to the British drugmaker’s decision to stop its clinical study of the new coronavirus vaccine, Stat News has reported.
The participant was recovering and will likely be discharged from the hospital within a day, according to Stat News, which said on Wednesday the new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors partici…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending